Investigating the Role of Lymph Nodes in Lung Cancer with Pleural Invasion

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to evaluate the significance of intrapulmonary lymph nodes in patients diagnosed with non-small cell lung cancer (NSCLC) who have visceral pleural invasion. It focuses on understanding whether the dissection of specific lymph nodes is necessary for accurate staging and treatment planning. The study will analyze samples from lymph node stations 12, 13, and 14 to assess their prognostic value. The research seeks to clarify the controversial impact of visceral pleural invasion on patient outcomes.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Anatomical resection for NSCLC \<3 cm (lobectomy, bilobectomy, segmentectomy)
* Samples from the intrapulmonary stations 12, 13, and 14 lymph nodes
* Resection of lymphnodes station 10 and 11 during hilar separation.
* R0 resection

Exclusion Criteria:

* Prior or synchronous lung cancer
* pN2
* Pneumonectomy
* R1/R2 resection
* M1
* Neoadjuvant treatment

Where it's running

• Kantonsspital Luzern
  Lucerne, Switzerland Recruiting

Study contacts

• Study coordinator: Fabrizio Minervini, MD, PhD
• Email: fabriziominervini@hotmail.com
• Phone: +410412051111

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Maximizing lymph node removal from lung surgery specimens

  This project will try a standardized dissection method to remove more lymph nodes from lung cancer surgery specimens so staging is more accurate for people having lobectomy without prior treatment.

  Recruiting Brigham and Women's Hospital · Boston, Massachusetts · NCT06252129

• ePRO in advanced lung cancer: emotional distress, brain metastasis, and symptom burden

  This study tests how patients with advanced lung cancer—some with brain metastases—report emotional distress and symptoms over time using electronic questionnaires.

  Recruiting Tongji Hospital · Hubei, Wuhan · NCT07912190

• Urine VOC Test to Detect Lung Cancer in Never Smokers

  A urine test that looks for volatile compounds is tested to see if it can help detect lung cancer in adults who have never smoked.

  Recruiting Thomas Jefferson University · Philadelphia, Pennsylvania · NCT07871656

• SI-B036 safety test in advanced and metastatic solid tumors

  This early-phase study checks whether SI-B036 is safe and tolerable in adults with advanced or metastatic solid cancers who have had prior therapy.

  Recruiting at 4 sites Phase 1 SystImmune Inc. · New Haven, Connecticut and 6 other locations · NCT07857616

• Guaraná Supplement for Cancer-Related Fatigue in People Undergoing Treatment

  This study tests whether taking guaraná capsules helps reduce cancer-related fatigue and improve quality of life in adults with breast, lung, colorectal, or gastric cancer who are actively receiving treatment.

  Recruiting Centro de Tratamiento e Investigación sobre Cáncer, Luis Carlos Sarmiento Angulo · Bogotá, Bogota D.C. · NCT07816263

• ENPP1/cGAS and FAP in Solid Tumors in Vietnamese Patients

  This Vietnam-based study will test ENPP1, cGAS, and FAP expression in archived tumor samples from Vietnamese adults with solid cancers using immunohistochemistry.

  Recruiting at 2 sites Tam Anh Research Institute · Hanoi, Hanoi and 1 other locations · NCT07808164

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.